IMPACT OF MULTIDRUG-RESISTANT BACTERIA INFECTIONS ON TREATMENT OUTCOMES IN PATIENTS WITH SEVERE BURNS
Main Article Content
Abstract
Objectives: To evaluate the impact of multidrug-resistant bacterial (MDRb) infections on mortality rate, superficial wound healing time, and treatment costs among patients with severe burns. Methods: A prospective, descriptive, longitudinal study was conducted on 131 severe burn patients treated at the Intensive Care Unit (ICU), National Burn Hospital Le Huu Trac, from January 2023 to December 2023. A total of 744 clinical specimens (blood, wound exudate, and urine) were analyzed. Results: Deep burn surface area and MDRb bloodstream infections were independently associated with mortality (p < 0.05). Each 1% increase in deep burn area was associated with a 1.07-fold increase in mortality risk, while the presence of MDRb in blood increased the risk 8.03-fold after adjustment for other factors. MDRb bloodstream infection showed moderate prognostic value for mortality (AUC = 0.75), with a sensitivity of 55.77% and a specificity of 93.67%. Patients with MDRb infection had significantly longer ICU stays, prolonged superficial wound healing, and higher treatment costs per 1% total burn surface area compared to those without MDR infections (p < 0.01). Conclusion: MDRb infections significantly increase mortality, prolong wound healing time, and elevate treatment costs in severe burn patients (p < 0.05). MDRb-positive blood cultures are an independent prognostic factor for mortality (p < 0.01).
Keywords
Multidrug-resistant bacterial, Burns, Mortality
Article Details
References
2. Martina NR, Wardhana A. Mortality analysis of adult burn patients. Journal Plastik Rekonstruksi. 2013; 2(2):96-100.
3. Tchakal-Mesbahi A, Abdouni M, Metref M. Prevalence of multidrug-resistant bacteria isolated from burn wounds in algeria. Annals of Burns and Fire Disasters. 2021; 34(2):150.
4. Magiorakos AP, Srinivasan A, Carey RB, et al. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: An international expert proposal for interim standard definitions for acquired resistance. Clinical microbiology and infection. 2012; 18(3):268-281.
5. Branski LK, Al-Mousawi A, Rivero H, et al. Emerging infections in burns. Surgical Infections. 2009, 10(5):389-397.
6. Gallaher JR, Banda W, Lachiewicz AM, et al. Colonization with multidrug-resistant Enterobacteriaceae is associated with increased mortality following burn injury in sub-Saharan Africa. World Journal of Surgery; 2018; 42:3089-3096.
7. Veronica RM, Nelwan EJ, Kumalawati J, et al. The effect of multidrug-resistant organism infection on mortality of burn patients at RSUPN Dr. Cipto Mangunkusumo. Annals of Burns and Fire Disasters. 2024; 37(2):159-168.
8. Cleland H, Tracy LM, Padiglione A, et al. Patterns of multidrug resistant organism acquisition in an adult specialist burns service: A retrospective review. Antimicrobial Resistance & Infection Control. 2022; 11(1):82.